Endocyte

Endocyte

Endocyte

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.
Founded
1996
Raised
$71M
Follow us
Alexa global traffic share
Latest funding Show all
$15,000,000
Venture capital - 2010
$26,000,000
Venture capital (Series C) - 2010
Team Size
1–10
Employees
Xconomy

Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

Health
Xconomy

Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters

Health Strategy